Around the Net

Sale Of Rx Business Allows P&G To Return To Its Roots

The sale of Procter & Gamble's prescription-drug unit to Warner Chilcott means that the company is losing a business that contributes more than $2 billion a year in sales. But it is gaining $3.1 billion in cash that it intends to re-invest in its core businesses of laundry, home care and personal care products, David Holthaus reports.

Prescription drugs can take years of R&D and regulatory battles before they come to market. P&G will now be able to focus on OTC products such as its Vicks cough and cold products, Crest and Oral-B oral care products, and Always and Tampax feminine care products.

"We're going to do what we have to do to get the right businesses together that will help us grow," says CEO Robert McDonald. "Most of these brands have significant global growth opportunities."

advertisement

advertisement

Read the whole story at Cincinnati Inquirer »

Next story loading loading..